Consumers to pharma: Let's be Facebook friends (or not)

Drugmakers often get a bad rap among consumers for questionable marketing practices and events like the Vioxx scandal. Yet a consumer survey shows that, at least in online circles, pharma isn't as unpopular as one might think. According to Manhattan Research's ePharma Consumer study, four out of 10 people want pharma groups to be active in online health communities, and only two out of 10 people surveyed believed that drugmakers should stay away from such forums. Those numbers could be enough to further embolden many drugmakers' efforts to attract audiences on Facebook, Twitter and YouTube. Release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.